CVS Health insider trading
Health Care · Net sellingShare price and insider trades
Valuation, profit and volume
Summary
Over the past 12 months, 0 CVS Health insiders reported open-market purchases totaling $0, while 2 insiders reported sales totaling $324M. 0 of 8 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales. 43 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| May 21SEC | Larry RobbinsDirector | Sell | 1,983,387 | $94.45 | $187M | -7.9% | — |
| May 21SEC | Larry RobbinsDirector | Sell | 797,628 | $93.48 | $74.6M | -6.9% | — |
| May 21SEC | Larry RobbinsDirector | Sell | 370,462 | $93.45 | $34.6M | -6.9% | — |
| May 21SEC | Larry RobbinsDirector | Sell | 152,691 | $94.81 | $14.5M | -8.2% | — |
| May 21SEC | Larry RobbinsDirector | Sell | 66,881 | $95.67 | $6.4M | -9.0% | — |
| May 21SEC | Larry RobbinsDirector | Sell | 800 | $96.28 | $77K | -9.6% | — |
| May 21SEC | Larry RobbinsDirector | Sell | 151 | $95.18 | $14K | -8.6% | — |
| May 11SEC | Tilak MandadiEvp, Chief Exp & Tech Officer | Sell | 69,551 | $89.58 | $6.2M | -2.9% | — |
| Jan 27SEC | Steven H NelsonPresident | Buy | 24 | $53.70 | $1K | +62.0% | — |
| Oct 14SEC | Heidi B CapozziEvp And Chief People Officer | Buy | 35 | $56.85 | $2K | +53.1% | — |
| Oct 14SEC | Heidi B CapozziEvp And Chief People Officer | Buy | 35 | $56.47 | $2K | +54.1% | — |
| Oct 14SEC | Heidi B CapozziEvp And Chief People Officer | Buy | 10 | $62.24 | $622 | +39.8% | — |
Insiders at CVS Health
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Larry RobbinsDirector | — | $317M | May 21, 2026 | — |
| Tilak MandadiEvp, Chief Exp & Tech Officer | — | $6.2M | May 11, 2026 | — |
| Heidi B CapozziEvp And Chief People Officer | $5K | — | Apr 2, 2026 | — |
| Steven H NelsonPresident | $1K | — | Apr 2, 2026 | — |
| James David ClarkSvp, Cont & Chief Acct Officer | — | — | Jun 29, 2026 | — |
| Amy Compton-phillipsEvp, Chief Medical Officer | — | — | Jun 1, 2026 | — |
| Brian NewmanCFO | — | — | Jun 1, 2026 | — |
| Fernando AguirreDirector | — | — | May 22, 2026 | — |
| Jeffrey R. BalserDirector | — | — | May 15, 2026 | — |
| C David Brown IIDirector | — | — | May 15, 2026 | — |
| Guy P SansoneDirector | — | — | May 15, 2026 | — |
| Leslie V NorwalkDirector | — | — | May 15, 2026 | — |
| J Scott KirbyDirector | — | — | May 15, 2026 | — |
| J. David JoynerCEO, President | — | — | Apr 2, 2026 | — |
| Prem S ShahPresident | — | — | Apr 2, 2026 | — |
| Samrat S. KhichiGeneral Counsel | — | — | Apr 2, 2026 | — |
| John E GallinaDirector | — | — | Mar 20, 2026 | — |
| Roger N FarahDirector | — | — | Dec 2, 2025 | — |
| Douglas H. ShulmanDirector | — | — | Nov 21, 2025 | — |
| Anne A. FinucaneDirector | — | — | Nov 21, 2025 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
Common questions about CVS insiders
Are CVS Health insiders buying CVS stock?
In the past 12 months, 0 insiders reported open-market purchases of CVS worth $0. The latest was President Steven H Nelson bought $1K of CVS at $53.70 — first open-market purchase in our records; opens a new position.
Are CVS Health insiders selling CVS stock?
2 insiders reported sales worth $324M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.